
|Videos|November 26, 2018
Recurrent HR+ Breast Cancer
Recurrent HR+ Breast Cancer
Advertisement
A 58-Year-Old Woman With Recurrent HR+ Breast Cancer
December 2013
- A 58-year-old postmenopausal woman was referred for further evaluation of a suspicious left-sided lesion found incidentally on routine mammogram
- MRI revealed a 4.3-cm lesion in her left breast
- PMH unremarkable
- She underwent lumpectomy with axillary staging
- Biopsy findings:
- Histology: lobular carcinoma, grade 2
- Hormone receptor status: ER+/ PR (-)
- HER2,IHC 1+
- OncotypeDx RS, 19
- Staging, T2N0M0
- ECOG 0
- She was started on adjuvant anastrozole
September 2018
- On routine follow-up, the patient reports increasing fatigue and intermittent bouts of abdominal pain with nausea
- CT with contrast showed several small lesions in the liver; biopsy confirmed metastatic disease.
- The patient was started on ribociclib; anastrozole was changed to fulvestrant
- Imaging at 3 and 6 months showed a partial response
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
ASCO 2026 GU Cancer Highlights: Beyond the LBAs
2
FDA Approves Generic Eribulin Mesylate for Metastatic Breast Cancer
3
Dr Cloughesy on Extended Follow-Up Data for Vorasidenib in IDH1/2 Mutant Glioma
4
Long-Term Outcomes Offer Reassurance on Quadruplet Use in Transplant-Ineligible NDMM
5

































